Achieving global immunity against hepatitis A through universal vaccination : a position paper from the European Society of Clinical Microbiology and Infectious Diseases Study Group for Viral Hepatitis
Hepatitis A virus (HAV) remains a preventable cause of acute viral hepatitis, with an estimated 159 million new infections and 39 000 deaths in 2019. Although improved care and hygiene reduced deaths, global incidence rose by approximately 4%, driven by increased symptomatic cases and population growth. The availability of safe and highly immunogenic vaccines and the absence of chronic carriage ma
